Evidence map›Paper›PMID 24732310›Full record

ArticlePloS one2014

The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis.

Xiaojiang Tan, Beth Burgwyn Fuchs, Yan Wang, Weiping Chen, Grace J Yuen, Rosalyn B Chen, Elamparithi Jayamani, Cleo Anastassopoulou, Read Pukkila-Worley, Jeffrey J Coleman and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. The unique Efg1 fungal virulence regulon in the catheterized bladder environment.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Silver(I) 1,10-Phenanthroline Complexes Are Active againstJournal of fungi (Basel, Switzerland) · 2023
    Article
  5. Biofilm Formation by Chromoblastomycosis FungiJournal of fungi (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
  11. Mechanism of Candida pathogenesis: revisiting the vital drivers.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Review
  12. Microorganisms · 2020
    Review
  13. Review
  14. Frontiers in microbiology · 2020
    Article
  15. Journal of fungi (Basel, Switzerland) · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Xiaojiang TanDepartment of Respiration, Overseas Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China; Department of Medicine, Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Beth Burgwyn FuchsDepartment of Medicine, Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Yan WangDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America; School of Pharmacy, Second Military Medical University, Shanghai, P. R. China.
Weiping ChenDepartment of Respiration, Overseas Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China.
Grace J YuenDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Immunology, Harvard Medical School, Boston, Massachusetts, United States of America.
Rosalyn B ChenPhillips Academy, Andover, Massachusetts, United States of America.
Elamparithi JayamaniDepartment of Medicine, Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Cleo AnastassopoulouDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Read Pukkila-WorleyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Jeffrey J ColemanDepartment of Medicine, Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Eleftherios MylonakisDepartment of Medicine, Infectious Diseases Division, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Massachusetts General Hospital · USRhode Island Hospital · USBrown University · USHarvard University · USNanfang Hospital · CNPhillips Academy · USSecond Military Medical University · CN

Funding

A C.elegans high-throughput assay for the identification of new antifungal agentsR01AI075286 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2008 to 2010
$1.3M
Innate Immune Recognition of Candida albicans Infection in a C. elegans ModelK08AI081747 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2010 to 2014
$684k
NIAID NIH HHS K08 AI081747NIAID NIH HHS R01 AI075286NIAID NIH HHS R21 AI070569
6 · The paper itself

Abstract

Candida albicans is a ubiquitous fungus, which can cause very serious and sometimes life-threatening infections in susceptible patients. We used Caenorhabditis elegans as a model host to screen a library of C. albicans mutants for decreased virulence and identified SPT20 as important for virulence. The transcription co-activator SPT20 was identified originally as a suppressor of Ty and solo δ insertion mutations, which can cause transcription defects in Saccharomyces cerevisiae. It is resistant to the toxicity caused by overexpression of GAL4-VP16. We constructed a C. albicans spt20Δ/Δ mutant and found the spt20Δ/Δ strain was significantly less virulent than the wild-type strain SC5314 in C. elegans (p < 0.0001), Galleria mellonella (p < 0.01) and mice (p < 0.001). Morphologically, spt20Δ/Δ mutant cells demonstrated a "snow-flake" shape and clustered together; prolonged culture times resulted in increased size of the cluster. The clustered morphology was associated with defects in nuclei distribution, as the nuclei were not observed in many cellular compartments. In addition, the C. albicans spt20Δ/Δ mutant resulted in defects in hyphae and biofilm formation (compared to the wild-type strain, p < 0.05), and sensitivity to cell wall and osmotic stressors, and to antifungal agents. Thus our study demonstrated a role of C. albicans SPT20 in overall morphology and distribution of nuclear material, which may cause the defects in filamentation and biofilm formation directly when this gene is deleted.

Indexed as

AnimalsAntifungal AgentsBenzenesulfonatesBiofilmsCaenorhabditis elegansCandida albicansCandidiasisCell NucleusCell WallDisease Models, AnimalFungal ProteinsHyphaeMiceMicrobial Sensitivity TestsMothsMutationAntifungal AgentsBenzenesulfonatesC.I. Fluorescent Brightening Agent 28Fungal Proteins

Identifiers

PMID24732310
PMCPMC3986095
OpenAlexW2099805287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.